16133-25-8Relevant articles and documents
Regioselective Lithiation of 3-Pyridylsulfonic Acid Derivatives: A Convenient Route to Various New 4-Substituted 3-Pyridylsulfonamides
Breant, P.,Marsais, F.,Queguiner, G.
, p. 822 - 824 (1983)
-
Synthetic method of pyridine-3-sulfonyl chloride
-
Paragraph 0028-0032, (2021/05/26)
The invention provides a synthetic method for synthesizing pyridine-3-sulfonyl chloride. The synthesis of pyridine-3-sulfonyl chloride comprises the following steps: taking 3-amino pyridine as an initial raw material, separating out an intermediate fluoboric acid diazonium salt, and then carrying out sulfonyl chlorination reaction. The method is low in cost, high in product content, convenient to operate, few in three wastes and suitable for industrial large-scale production.
Environment-friendly chemical synthetic method for 3-pyridine sulfonyl chloride
-
Paragraph 0052; 0054-0083, (2017/04/03)
The invention provides an environment-friendly chemical synthetic method for 3-pyridine sulfonyl chloride. The method comprises the steps of carrying out diazo-reaction, substitution reaction, extraction and distillation on 3-aminopyridine as a starting material, so as to obtain 3-pyridine sulfonyl chloride. By virtue of the method, acylation reagents such as pentachloride phosphorus oxychloride is not used, and reaction conditions are mild, so that the method for producing 3-pyridine sulfonyl chloride belongs to green chemistry, meanwhile, the reaction time is greatly shortened, the yield of the product is increased to be above 80%, and the production cost is greatly lowered.
Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide
Gunaga, Prashantha,Lloyd, John,Mummadi, Somanadham,Banerjee, Abhisek,Dhondi, Naveen Kumar,Hennan, James,Subray, Veena,Jayaram, Ramya,Rajugowda, Nagendra,Umamaheshwar Reddy, Kommuri,Kumaraguru, Duraimurugan,Mandal, Umasankar,Beldona, Dasthagiri,Adisechen, Ashok Kumar,Yadav, Navnath,Warrier, Jayakumar,Johnson, James A.,Sale, Harinath,Putlur, Siva Prasad,Saxena, Ajay,Chimalakonda, Anjaneya,Mandlekar, Sandhya,Conder, MaryLee,Xing, Dezhi,Gupta, Arun Kumar,Gupta, Anuradha,Rampulla, Richard,Mathur, Arvind,Levesque, Paul,Wexler, Ruth R.,Finlay, Heather J.
, p. 3795 - 3803 (2017/05/19)
We have recently disclosed 5-phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine 1 as a potent IKur current blocker with selectivity versus hERG, Na and Ca channels, and an acceptable preclinical PK profile. Upon further characterization in vivo, compound 1 demonstrated an unacceptable level of brain penetration. In an effort to reduce the level of brain penetration while maintaining the overall profile, SAR was developed at the C2′ position for a series of close analogues by employing hydrogen bond donors. As a result, 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide (25) was identified as the lead compound in this series. Compound 25 showed robust effects in rabbit and canine pharmacodynamic models and an acceptable cross-species pharmacokinetic profile and was advanced as the clinical candidate. Further optimization of 25 to mitigate pH-dependent absorption resulted in identification of the corresponding phosphoramide prodrug (29) with an improved solubility and pharmacokinetic profile.